ATE253381T1 - Verfahren zur detektion und lokalisation maligner meschlicher tumore des pankreas - Google Patents
Verfahren zur detektion und lokalisation maligner meschlicher tumore des pankreasInfo
- Publication number
- ATE253381T1 ATE253381T1 AT98904839T AT98904839T ATE253381T1 AT E253381 T1 ATE253381 T1 AT E253381T1 AT 98904839 T AT98904839 T AT 98904839T AT 98904839 T AT98904839 T AT 98904839T AT E253381 T1 ATE253381 T1 AT E253381T1
- Authority
- AT
- Austria
- Prior art keywords
- pancreas
- detecting
- composition
- relates
- neurotensin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/085—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being neurotensin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97200297 | 1997-02-03 | ||
PCT/US1998/001964 WO1998033531A1 (en) | 1997-02-03 | 1998-02-02 | Method for the detection and localization of malignant human tumours |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE253381T1 true ATE253381T1 (de) | 2003-11-15 |
Family
ID=26146106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98904839T ATE253381T1 (de) | 1997-02-03 | 1998-02-02 | Verfahren zur detektion und lokalisation maligner meschlicher tumore des pankreas |
Country Status (11)
Country | Link |
---|---|
US (2) | US6312661B1 (de) |
EP (1) | EP0968001B1 (de) |
JP (1) | JP2001511152A (de) |
AT (1) | ATE253381T1 (de) |
AU (1) | AU728712C (de) |
CA (1) | CA2279530C (de) |
DE (1) | DE69819478T2 (de) |
HU (1) | HUP0001316A3 (de) |
IL (1) | IL131386A0 (de) |
NO (1) | NO993846L (de) |
WO (1) | WO1998033531A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3340699B2 (ja) * | 1998-06-05 | 2002-11-05 | 東京瓦斯株式会社 | 膵外分泌機能診断剤 |
US7232559B1 (en) | 1999-06-04 | 2007-06-19 | Tokyo Gas Company Limited | Diagnostic agents for pancreatic exocrine function |
WO2001030398A2 (en) * | 1999-10-22 | 2001-05-03 | Insight Neuroimaging Systems, Llc | Ligand chelated paramagnetic mri contrast agents |
US7630907B2 (en) * | 2001-10-30 | 2009-12-08 | Biodose, Llc | Algorithm and program for the handling and administration of radioactive pharmaceuticals |
US8175890B2 (en) * | 2001-10-30 | 2012-05-08 | Biodose, Llc | Pharmacy based method and algorithm for handling of radioactive pharmaceuticals and generating of reports therefrom |
US7261876B2 (en) | 2002-03-01 | 2007-08-28 | Bracco International Bv | Multivalent constructs for therapeutic and diagnostic applications |
US7794693B2 (en) | 2002-03-01 | 2010-09-14 | Bracco International B.V. | Targeting vector-phospholipid conjugates |
US7211240B2 (en) | 2002-03-01 | 2007-05-01 | Bracco International B.V. | Multivalent constructs for therapeutic and diagnostic applications |
US8623822B2 (en) | 2002-03-01 | 2014-01-07 | Bracco Suisse Sa | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
EP1587944A4 (de) * | 2002-03-01 | 2007-03-21 | Dyax Corp | Kdr und vegf/kdr-bindende peptide und ihre diagnostische und therapeutische veranwendung bei der diagnose und therapie |
US20040039241A1 (en) * | 2002-05-29 | 2004-02-26 | Biodose Llc | Integrated distribution and communication process and algorithm for providing, handling, distributing or generating reports regarding radioactive pharmaceuticals |
AU2003259172A1 (en) * | 2002-07-24 | 2004-02-09 | The Salk Institute For Biological Studies | Receptor (sstr4)- selective somatostatin analogs |
GR1004637B (el) * | 2003-04-04 | 2004-07-23 | Βιομεντικααλαιφασαιενσισαανωνυμηαεταιριααφαρμακευτικωναπροιοντωναα | Συνθεσηαβιολογικηακαιαπροκλινικηααξιολογησηααναλογωνανευροτενσινησα}@@bατροποποιημενωναμεαπαραγωγαατουα@ϊ@τετρααζαενδεκανιουα}@ϊ@tetraazaundecanebακαιαεπισημασμενωναμεατεχνητιο@mα}αηαλλααραδιονουκλιδιαατουατεχνητιουbαη@καιαρηνιο@ϊϊα}΄ηααλλααραδιονουκλιδιαατουαρηνιουbαγιααεφαρμογηαστηναογκολογιαα |
BRPI0414512B8 (pt) * | 2003-09-17 | 2021-05-25 | Board Of Regentes The Univ Of Texas System | composição para reproduzir imagens de um pâncreas e uso desta |
US20060062729A1 (en) * | 2004-09-09 | 2006-03-23 | Carraway Robert E | Enhanced ligand binding to neurotensin receptors |
US7507547B2 (en) * | 2004-09-09 | 2009-03-24 | University Of Massachusetts | Screening assays for antioxidants and antiproliferative compounds |
ES2538002T3 (es) | 2009-01-07 | 2015-06-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Métodos para el tratamiento, la evaluación pronóstica y la detección de cáncer de mama |
WO2011006985A1 (en) * | 2009-07-16 | 2011-01-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors |
US8378134B2 (en) | 2009-09-30 | 2013-02-19 | General Electric Company | Hydroxylated contrast enhancement agents |
EP2740726A1 (de) | 2012-12-07 | 2014-06-11 | 3B Pharmaceuticals GmbH | Neurotensin-Rezeptorligande |
JP7065567B2 (ja) | 2014-06-10 | 2022-05-12 | スリービー・ファーマシューティカルズ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | ニューロテンシン受容体リガンドを含むコンジュゲートおよびそれらの使用 |
EP2954933A1 (de) | 2014-06-10 | 2015-12-16 | 3B Pharmaceuticals GmbH | Konjugat mit einem Neurotensinrezptorligand |
EP2954934A1 (de) | 2014-06-11 | 2015-12-16 | 3B Pharmaceuticals GmbH | Konjugat aus einem Neurotensinrezeptorliganden und Verwendung davon |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2687680A1 (fr) * | 1992-02-20 | 1993-08-27 | Centre Nat Rech Scient | Procede de marquage de proteines et de peptides par acylation de leur fonction alpha aminee par un reactif comportant une fonction carboxylique activee. |
CA2131315A1 (en) * | 1992-03-25 | 1993-09-30 | Geert J. Ensing | Method of intraoperatively detecting and locating tumoral tissues |
CA2086453A1 (en) * | 1992-12-30 | 1994-07-01 | Mcgill University | Marker for neurotensin receptor |
DE4337599A1 (de) * | 1993-11-01 | 1995-05-04 | Diagnostikforschung Inst | Metallbindende cysteinfreie Peptide für Diagnose und Therapie, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
CA2183421A1 (en) * | 1994-02-18 | 1995-08-24 | John Mertens | Labelled peptide compounds |
FR2720066B1 (fr) * | 1994-05-20 | 1996-06-28 | Rhone Poulenc Rorer Sa | Peptides antagonistes de la neurotensine. |
FR2722193B1 (fr) * | 1994-07-08 | 1996-10-04 | Sanofi Sa | Derives n-oxydes de 1-(7-chloro-4-quinoleinyl)pyrazole-3-carboxamides substitues, procede pour leur preparation et les compositions pharmaceitiques les contenant |
WO1996023527A1 (en) * | 1995-02-03 | 1996-08-08 | Mallinckrodt Medical, Inc. | Method for the detection and localization of malignant human tumours |
-
1998
- 1998-02-02 AT AT98904839T patent/ATE253381T1/de not_active IP Right Cessation
- 1998-02-02 DE DE69819478T patent/DE69819478T2/de not_active Expired - Lifetime
- 1998-02-02 JP JP53317698A patent/JP2001511152A/ja active Pending
- 1998-02-02 WO PCT/US1998/001964 patent/WO1998033531A1/en not_active Application Discontinuation
- 1998-02-02 EP EP98904839A patent/EP0968001B1/de not_active Expired - Lifetime
- 1998-02-02 US US09/355,869 patent/US6312661B1/en not_active Expired - Lifetime
- 1998-02-02 AU AU62622/98A patent/AU728712C/en not_active Ceased
- 1998-02-02 CA CA002279530A patent/CA2279530C/en not_active Expired - Lifetime
- 1998-02-02 IL IL13138698A patent/IL131386A0/xx unknown
- 1998-02-02 HU HU0001316A patent/HUP0001316A3/hu unknown
-
1999
- 1999-08-10 NO NO993846A patent/NO993846L/no not_active Application Discontinuation
-
2001
- 2001-11-05 US US09/985,672 patent/US20020155064A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20020155064A1 (en) | 2002-10-24 |
AU6262298A (en) | 1998-08-25 |
NO993846D0 (no) | 1999-08-10 |
IL131386A0 (en) | 2001-01-28 |
HUP0001316A2 (hu) | 2000-09-28 |
HUP0001316A3 (en) | 2001-10-29 |
EP0968001A1 (de) | 2000-01-05 |
US6312661B1 (en) | 2001-11-06 |
CA2279530C (en) | 2009-04-28 |
CA2279530A1 (en) | 1998-08-06 |
NO993846L (no) | 1999-09-09 |
WO1998033531A1 (en) | 1998-08-06 |
AU728712C (en) | 2001-07-19 |
AU728712B2 (en) | 2001-01-18 |
EP0968001B1 (de) | 2003-11-05 |
DE69819478D1 (de) | 2003-12-11 |
DE69819478T2 (de) | 2004-09-02 |
JP2001511152A (ja) | 2001-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE253381T1 (de) | Verfahren zur detektion und lokalisation maligner meschlicher tumore des pankreas | |
CN101631801B (zh) | 受体(sstr2)-选择性生长抑素拮抗剂 | |
Tjuvajev et al. | Iododeoxyuridine uptake and retention as a measure of tumor growth | |
US20130330274A1 (en) | Compositions and methods for detecting and treating cancer | |
US10166302B2 (en) | Labeling composition for cancer lesion | |
Bogdanov Jr et al. | Treatment of experimental brain tumors with trombospondin-1 derived peptides: an in vivo imaging study | |
Kahán et al. | Inhibition of growth of MX‐1, MCF‐7‐MIII and MDA‐MB‐231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN‐238 | |
US20060188441A1 (en) | Radiolabeled gallium complexes, methods for synthesis and use for PET imaging of EGFR expression in malignant tumors | |
N Eberle et al. | Synthetic peptide drugs for targeting skin cancer: malignant melanoma and melanotic lesions | |
O'Byrne et al. | Scintigraphic imaging of small-cell lung cancer with [111In] pentetreotide, a radiolabelled somatostatin analogue | |
US9180214B1 (en) | Gonadotropin-releasing hormone receptor-targeting peptides and their use to treat and diagnose cancer | |
Guo et al. | A novel indium-111-labeled gonadotropin-releasing hormone peptide for human prostate cancer imaging | |
KR102396324B1 (ko) | 인 시츄 면역 조절 암 백신화를 위한 표적화된 방사선요법 킬레이트 | |
KR20170104398A (ko) | Glypican-3에 선택적으로 결합하는 압타머 및 이의 용도 | |
Nock et al. | Theranostic perspectives in prostate cancer with the GRPR-antagonist NeoBOMB1–preclinical and first clinical results | |
Liu et al. | In vivo imaging of human colorectal cancer using radiolabeled analogs of the uroguanylin peptide hormone | |
JP2022517662A (ja) | 腫瘍細胞外マトリックスにおける腫瘍性タンパク質に特異的なペプチドpet/spectプローブ | |
JP2002516882A5 (de) | ||
JP2005514335A (ja) | 腫瘍イメージング及び治療のためのpacap組成物及び方法 | |
WO1997031657A3 (en) | Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors | |
US20170326166A1 (en) | Compositions and methods for treating pituitary tumors | |
Keenan | Immunolymphoscintigraphy | |
Varshney et al. | Targeting Bombesin Peptide Receptors for Cancer Imaging: Perspective in Prostate, Lung and Breast Cancer | |
US11213597B2 (en) | Kinin-based theranostic probes for solid cancers and uses thereof | |
Kinuya et al. | Short-period-induced hypertension could improve tumor-to-nontumor ratios of radiolabeled monoclonal antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |